Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-03

FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved Oceanside Pharmaceuticals' supplemental application for pyridostigmine bromide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

SUPPL AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)